Cancer vaccines: between the idea and the reality
- 1 August 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Immunology
- Vol. 3 (8), 630-641
- https://doi.org/10.1038/nri1150
Abstract
Whether vaccines are designed to prepare the immune system for the encounter with a pathogen or with cancer, certain common challenges need to be faced, such as what antigen and what adjuvant to use, what type of immune response to generate and how to make it long lasting. Cancer, additionally, presents several unique hurdles. Cancer vaccines must overcome immune suppression exerted by the tumour, by previous therapy or by the effects of advanced age of the patient. If used for cancer prevention, vaccines must elicit effective long-term memory without the potential of causing autoimmunity. This article addresses the common and the unique challenges to cancer vaccines and the progress that has been made in meeting them. Considering how refractory cancer has been to standard therapy, efforts to achieve immune control of this disease are well justified.Keywords
This publication has 137 references indexed in Scilit:
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003
- Colorectal polyps and other precursor lesions: Need for an expanded viewGastroenterology Clinics of North America, 2002
- Immunoprevention of colorectal cancer: a future possibility?Gastroenterology Clinics of North America, 2002
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Mucosal addressin expression and binding-interactions with naive lymphocytes vary among the cranial, oral, and nasal-associated lymphoid tissuesEuropean Journal of Immunology, 2002
- Interaction of Heat Shock Proteins with Peptides and Antigen Presenting Cells: Chaperoning of the Innate and Adaptive Immune ResponsesAnnual Review of Immunology, 2002
- Innate immunity: Lipoproteins take their Toll on the hostCurrent Biology, 1999
- Strategies for the development of recombinant vaccines for the immunotherapy of breast cancerBreast Cancer Research and Treatment, 1996
- MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer VaccinesImmunological Reviews, 1995
- Immunogenicity of a polyvalent melanoma antigen vaccine in humansCancer, 1988